🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

December at MD Anderson Cancer Center

#AI #PrecisionMedicine #meded #livertwitter 👏a highly recommended REVIEW on the hot topic: "Artificial intelligence and its role in guiding liver-directed therapy for #HCC: Is it ready for prime time?" from Dr. Elena Panettieri's team Elena Panettieri 🔗oaepublish.com/articles/downl…

Great teamwork, as usual! Eduardo A. Vega

Another MD Anderson Cancer Center CGSO fellowship highlight - journal clubs! Monthly specialty-specific get togethers. Tonight? HPB. Good food. Good company. Good science.

Check it out, our article, "🌐Global Practice Patterns of Preoperative 3D Image Reconstructions for Liver Surgery," is now available online👇 🆓🔗 authors.elsevier.com/c/1iSfs,Op-42C… Elena Panettieri Oscar Salirrosas Claudius Conrad Ariana Maria Chirban Satoshi Ogiso, MD, PhD, FACS JOGS andrea ruzzenente

Is adjuvant treatment really helping to improve survival after R1 resection for perihilar cholangiocarcinoma? Are we overtreating these patients? Are we adequately assessing margins? Check our results just published in JOGS Eduardo A. Vega Cholangiocarcinoma Foundation sciencedirect.com/science/articl…

Well done 👏🏼👏🏼 it’s interesting to note there’s no observable benefit of adjuvant chemo in R1-resected patients (or in fact in any resected patient ascopubs.org/doi/10.1200/JC… ) highlighting uncertainty re BILCAP’s generalizability. What do you do at your institutions ?

Just wrapped up a productive trip to Niseko and Nagoya, 🇯🇵! Excited to announce the expansion of Gallbladder collaboration with HPB-SNOW research group. Grateful to Dr. Yoji Kishi, Dr. Hiromichi Ito ATLAS project by National Cancer Center, Japan , Dr. Takashi Mizuno @nagoyauniv, and Dr. Takehiro Noji

There’s still time to sign up for the Early Career Group Pre-Congress Retreat at the IHPBA 2024 World Congress. There is no charge if you’re already signed up for the congress. Take a look at some highlights from our programme. Visit ihpba2024.org to register.

EXCELLENT talk by Elena Panettieri on the opportunities available to becoming an #HPB surgeon from an international background. Amazing experiences and advice! She is a ⭐️🌟⭐️🌟⭐️🌟 #ECG IHPBA AHPBA E-AHPBA Jean-Nicolas Vauthey MD Ching-Wei D. Tzeng Hop S. Tran Cao The AHPBA Podcast #oncsurgery

Thank you for the support and mentorship!

It was great to meet mentors and friends and have the chance to share my work at the 2024 IHPBA world conference in such a unique scenery as Cape Town. Special thanks to Jean-Nicolas Vauthey MD Timothy Newhook Ching-Wei D. Tzeng Yoshikuni Kawaguchi @BVisserMD Hop S. Tran Cao for the continuous support!

New📰Annals of Surgical Oncology highlights 🔑 between squamous cell carcinoma (SCC) and adenocarcinoma (ADC) in BTC. 🟦SCC larger, higher-grade, and worse OS 🟦w resection OS SCC🟰ADC Jad Mitri Elena Panettieri Syed Kashif Mahmood, MD MPH FASGE Belen Rivera Cholangiocarcinoma Foundation Boston U Chobanian & Avedisian School of Medicine 📰👉 rdcu.be/dTA1I

Better late than never to post some photos from my graduation and amazing fellowship year at MD Anderson Cancer Center!

Comming Soon! Futile surgery in gallbladder cancer is predictable! 🔍 Our international study analyzed 788 patients and identified key risk factors for non-beneficial surgery: ✔ T3-T4 tumor stage (OR 2.20) ✔ Lymph node involvement (OR 1.91) ✔ Multi-visceral resection (OR 2.25)

Members stopping for a photo at the SSAT Hub at DDW 2025

It was such a pleasure to attend the annual SSAT meeting and be able to present my work and reunite with friends and mentors from around the world! Jean-Nicolas Vauthey MD Yoshikuni Kawaguchi Brittany C. Fields, MD, MPH Timothy Newhook Marcello Di Martino Ching-Wei D. Tzeng

🚨 New multicenter study on Advanced Gallbladder Cancer (T3/T4) just out JOGS ! 👉Belen Rivera Ariana Maria Chirban Elena Panettieri 🔍 419 patients from 17 institutions 🔪 OER = high morbidity, esp. in T4 ❗️44% of T3 were incidental 📉 T4 = poor outcomes ⚠️ Caution

Another productive E-AHPBA conference just came to an end. Honored to have been nominated to sit on the Scientific and Research Committee under the guidance of Anita Balakrishnan! Ching-Wei D. Tzeng Hop S. Tran Cao Brittany C. Fields, MD, MPH Adelina Leong MD Anderson Cancer Center Università Cattolica